ask="24.90"
ask_size="800"
average_daily_volume="670403"
bid="24.00"
bid_size="100"
book_value="5.75"
change="-4.10"
change_from_200_day_moving_average="6.04"
change_from_50_day_moving_average="6.31"
change_from_52_week_high="-4.70"
change_From_52_week_low="12.16"
change_in_percent="-14.39%"
close="24.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.25"
ebitda="-70.16M"
eps_estimate_current_year="-2.39"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.79"
ex_dividend_date="N/A"
float_shares="23150000"
high="26.50"
high_52_weeks="29.10"
last_trade_date="2/22/2017"
last_trade_price="24.40"
last_trade_size="261858"
last_trade_time="4:00pm"
low="23.55"
low_52_weeks="12.24"
market_capitalization="910.51M"
moving_average_200_day="18.36"
moving_average_50_day="18.09"
name="Global Blood Therapeutics
Inc."
notes="N/A"
one_year_target_price="50.83"
open="25.65"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+32.88%"
percent_change_from_50_day_moving_average="+34.91%"
percent_change_from_52_week_high="-16.15%"
percent_change_from_52_week_low="+99.35%"
previous_close="28.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.95"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37316000"
short_ratio="9.70"
stock_exchange="NMS"
symbol="GBT"
volume="8239076"
weeks_range_52="12.24 - 29.10"
